Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127066221 | 12706622 | 1 | I | 20160504 | 20160819 | 20160901 | 20160901 | EXP | GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-122764 | RANBAXY | 40.00 | YR | M | Y | 83.00000 | KG | 20160901 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127066221 | 12706622 | 1 | PS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | 500 MG, BID | 54958 | MG | U | U | 75747 | 500 | MG | Q12H | |||
| 127066221 | 12706622 | 2 | C | ALZAIN | 2 | Unknown | 1 DF, BID | U | U | 0 | 1 | DF | Q12H | ||||||
| 127066221 | 12706622 | 3 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 1 DF, QD | U | U | 0 | 1 | DF | ||||||
| 127066221 | 12706622 | 4 | C | DERMOL | BENZALKONIUM CHLORIDECHLORHEXIDINE HYDROCHLORIDEISOPROPYL MYRISTATEPARAFFIN | 1 | Unknown | FOR WASHING. | U | U | 0 | 1 | DF | ||||||
| 127066221 | 12706622 | 5 | C | PREGABALIN. | PREGABALIN | 1 | Unknown | 1 DF, BID | U | U | 0 | 1 | DF | Q12H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127066221 | 12706622 | 1 | Prostatitis |
| 127066221 | 12706622 | 2 | Product used for unknown indication |
| 127066221 | 12706622 | 3 | Product used for unknown indication |
| 127066221 | 12706622 | 4 | Product used for unknown indication |
| 127066221 | 12706622 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127066221 | 12706622 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127066221 | 12706622 | Abdominal pain | |
| 127066221 | 12706622 | Arthralgia | |
| 127066221 | 12706622 | Bradyphrenia | |
| 127066221 | 12706622 | Constipation | |
| 127066221 | 12706622 | Dermatitis contact | |
| 127066221 | 12706622 | Dyspnoea | |
| 127066221 | 12706622 | Fatigue | |
| 127066221 | 12706622 | Feeling abnormal | |
| 127066221 | 12706622 | Hair colour changes | |
| 127066221 | 12706622 | Heart rate increased | |
| 127066221 | 12706622 | Inguinal mass | |
| 127066221 | 12706622 | Insomnia | |
| 127066221 | 12706622 | Joint stiffness | |
| 127066221 | 12706622 | Malaise | |
| 127066221 | 12706622 | Muscle twitching | |
| 127066221 | 12706622 | Nausea | |
| 127066221 | 12706622 | Night sweats | |
| 127066221 | 12706622 | Palpitations | |
| 127066221 | 12706622 | Rash | |
| 127066221 | 12706622 | Suicidal ideation | |
| 127066221 | 12706622 | Vision blurred | |
| 127066221 | 12706622 | Vitreous floaters |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127066221 | 12706622 | 1 | 20160310 | 0 | ||
| 127066221 | 12706622 | 2 | 20160620 | 0 | ||
| 127066221 | 12706622 | 3 | 20160510 | 20160607 | 0 | |
| 127066221 | 12706622 | 4 | 20140514 | 0 | ||
| 127066221 | 12706622 | 5 | 20160602 | 20160603 | 0 |